These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 16423468)

  • 1. Oxidative stress may underlie the sex differences seen in steroid-induced osteonecrosis models.
    Ichiseki T; Matsumoto T
    Med Hypotheses; 2006; 66(6):1256. PubMed ID: 16423468
    [No Abstract]   [Full Text] [Related]  

  • 2. Does oxidative stress play a role in steroid-induced osteonecrosis models?
    Ichiseki T; Kaneuji A; Kitamura K; Matsumoto T
    Med Hypotheses; 2006; 66(5):1048. PubMed ID: 16413136
    [No Abstract]   [Full Text] [Related]  

  • 3. Oxidative stress by glutathione depletion induces osteonecrosis in rats.
    Ichiseki T; Ueda Y; Katsuda S; Kitamura K; Kaneuji A; Matsumoto T
    Rheumatology (Oxford); 2006 Mar; 45(3):287-90. PubMed ID: 16303823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Oxidative stress on idiopathic osteonecrosis].
    Matsumoto T; Kitamura K; Ichiseki T; Kaneuji A; Sugimori T
    Clin Calcium; 2007 Jun; 17(6):887-91. PubMed ID: 17548928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender difference in the development of steroid-induced osteonecrosis in rabbits.
    Ikemura S; Yamamoto T; Nishida K; Motomura G; Iwamoto Y
    Rheumatology (Oxford); 2010 Jun; 49(6):1128-32. PubMed ID: 20236951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal models of osteonecrosis of the jaw.
    Allen MR
    J Musculoskelet Neuronal Interact; 2007; 7(4):358-60. PubMed ID: 18094512
    [No Abstract]   [Full Text] [Related]  

  • 7. Oxidative stress and vascular permeability in steroid-induced osteonecrosis model.
    Ichiseki T; Matsumoto T; Nishino M; Kaneuji A; Katsuda S
    J Orthop Sci; 2004; 9(5):509-15. PubMed ID: 15449127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Animal models for steroid-induced osteonecrosis].
    Yamamoto T; Miyanishi K; Motomura G; Nishida K; Iwamoto Y; Sueishi K
    Clin Calcium; 2007 Jun; 17(6):879-86. PubMed ID: 17548927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for developing osteonecrosis after prophylaxis in steroid-treated rabbits.
    Motomura G; Yamamoto T; Miyanishi K; Kondo K; Hirota Y; Iwamoto Y
    J Rheumatol; 2008 Dec; 35(12):2391-4. PubMed ID: 19004034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous occurrence of both insufficient neovascularization and elevated vascular permeability in rabbit proximal femur during inadequate repair of steroid-associated osteonecrotic lesions.
    Zhang G; Sheng H; He YX; Xie XH; Wang YX; Lee KM; Yeung KW; Li ZR; He W; Griffith JF; Leung KS; Qin L
    Arthritis Rheum; 2009 Oct; 60(10):2966-77. PubMed ID: 19790047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous regression of steroid-related osteonecrosis of the knee.
    Takao M; Sugano N; Nishii T; Miki H; Yoshikawa H
    Clin Orthop Relat Res; 2006 Nov; 452():210-5. PubMed ID: 16788401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Physiopathological interpretation and progress in diagnosis and treatment. 8. Steroid-induced osteonecrosis].
    Nagasawa K
    Nihon Naika Gakkai Zasshi; 2000 Oct; 89(10):2122-7. PubMed ID: 11215127
    [No Abstract]   [Full Text] [Related]  

  • 13. Steroid treatment and osteonecrosis: comment on the article by Yamamoto et al.
    Le Parc JM; Paolaggi JB
    Arthritis Rheum; 1998 Sep; 41(9):1709-10. PubMed ID: 9751112
    [No Abstract]   [Full Text] [Related]  

  • 14. Bisphosphonate induced osteonecrosis of the jaws: unravelling uncertainty in disease causality.
    Kelleher FC; McKenna M; Collins C; Brady G; Collins I; Crown J
    Acta Oncol; 2007; 46(5):702-4. PubMed ID: 17562449
    [No Abstract]   [Full Text] [Related]  

  • 15. [Aseptic osteonecrosis: a sequestric transformation? (author's transl)].
    Perren SM; Rahn BA; Lüthi U; Gunst MA; Pfister U
    Orthopade; 1981 Jan; 10(1):3-5. PubMed ID: 7243268
    [No Abstract]   [Full Text] [Related]  

  • 16. [Steroid therapy and osteonecrosis].
    Nagasawa K
    Nihon Naika Gakkai Zasshi; 2002 Sep; 91 Suppl():262-8. PubMed ID: 12580127
    [No Abstract]   [Full Text] [Related]  

  • 17. Sex differences in oxidative stress and the impact on blood pressure control and cardiovascular disease.
    Sartori-Valinotti JC; Iliescu R; Fortepiani LA; Yanes LL; Reckelhoff JF
    Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):938-45. PubMed ID: 17645644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell biology during repair of osteonecrosis: implications for rational treatment.
    Glimcher MJ
    Acta Orthop Belg; 1999; 65 Suppl 1():17-22. PubMed ID: 10084212
    [No Abstract]   [Full Text] [Related]  

  • 19. Steroid-Induced Osteonecrosis in Dermatology: A Review.
    Nowak DA; Yeung J
    J Cutan Med Surg; 2015; 19(4):358-60. PubMed ID: 25825195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phytoestrogenic compounds for prevention of steroid-associated osteonecrosis.
    Qin L; Zhang G; Sheng H; Wang XL; Wang YX; Yeung KW; Griffith JF; Li ZR; Leung KS; Yao XS
    J Musculoskelet Neuronal Interact; 2008; 8(1):18-21. PubMed ID: 18398255
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.